首页> 外文期刊>Microbial drug resistance: MDR : Mechanisms, epidemiology, and disease >Colistin Increases the Cidal Activity of Antibiotic Combinations Against Multidrug-Resistant Klebsiella pneumoniae: An In Vitro Model Comparing Multiple Combination Bactericidal Testing at One Peak Serum Concentration and Time-Kill Method
【24h】

Colistin Increases the Cidal Activity of Antibiotic Combinations Against Multidrug-Resistant Klebsiella pneumoniae: An In Vitro Model Comparing Multiple Combination Bactericidal Testing at One Peak Serum Concentration and Time-Kill Method

机译:Colistin增加抗多种药物耐药肺炎克雷伯菌的抗生素组合的杀灭活性:在一个峰值血清浓度和时间杀伤方法比较多种组合杀菌试验的体外模型。

获取原文
获取原文并翻译 | 示例
           

摘要

The lack of treatment for multidrug-resistant (MDR) Enterobacteriaceae often leads to the use of double or triple antibiotic combinations to increase the option of clinical success. This study analyzes multiple combination bactericidal testing (MCBT) to screen double and triple antibiotic combinations, at standard peak serum concentration, for bactericidal activity against 21 MDR Klebsiella pneumoniae isolates. This method was compared with time-killing curves. The full bactericidal activity against all strains was obtained only by adding colistin. MCBT has a potential to become a rapid method for testing multiple antibiotic combinations for MDR micro-organisms when colistin is used, providing clinicians with in vitro cidal data within 48 hr of strain isolation.
机译:缺乏对多药耐药(MDR)肠杆菌科的治疗常常导致使用双重或双重抗生素组合以增加临床成功的可能性。这项研究分析了多重组合杀菌试验(MCBT),以筛选标准血清峰值浓度下的双重和三次抗生素组合,以检测针对21种MDR肺炎克雷伯菌肺炎分离株的杀菌活性。将该方法与消光曲线进行了比较。仅通过添加大肠菌素可获得对所有菌株的全部杀菌活性。当使用大肠菌素时,MCBT有可能成为测试多种抗生素组合用于MDR微生物的快速方法,为临床医生在菌株分离后48小时内提供体外杀灭数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号